ADM and hydrops fetalis: A phase 1 clinical trial indicated that adrenomedullin at 15 ng/kg/min may be effective for treating HF by reducing pulmonary edema through the stabilization of endothelial barrier function without notable hemodynamic or humoral effects [10].